Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PDUFA Reaches Approval Altitude; Can House Maintain Senate Speed?

Executive Summary

After about a week of debate, the Senate overwhelmingly passes its FDA user fee package, with only track and trace to be finalized. House members are scheduled to begin floor debate after Memorial Day in the hopes of sending the bill to President Obama before July 4.

Advertisement

Related Content

PDUFA Cost Offset In House Focuses On FDA Petition Review, Not REMS
Opioid Prescriber Education Mandate Could Be Added To User Fee Bill
User Fee Bill Reemerges In Senate With Minor Tweaks, But More Changes Expected
User Fee Legislation Revs Through Senate Mark-up, But House Bill Goes Back Into The Shop
FDA’s Globalization Strategy Needs To Be More Aggressive, Sen. Brown Suggests
Antibiotic Incentives: FDA’s Woodcock Says LPAD Could Be Better Than Exclusivity, But Questions Remain
FDA Spyware Suit: Whistleblowers Challenge Agency Over Email Surveillance
ClinicalTrials.gov: NIH Busy Educating Sponsors On Mandates While Regs Remain In The Works
FTC Rulemaking Could Be Next (And Last?) Attempt To Curb "Pay-For-Delay"
Patent Settlement Bill Advances - And Firms Fight Back With Examples Of Early Generic Launches That Would Be Prohibited

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS054476

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel